Skip to main content
Yanjiu Conference logo

Call for Papers – ICCVTI 2027, Makassar

International Conference on Cancer Vaccines and Tumor Immunology — ICCVTI 2027

Dates

25–26 March 2027

Venue

Makassar, Indonesia

Field

Cancer Vaccines and Tumor Immunology

Topics of ICCVTI 2027

Original papers are invited in Cancer Vaccines and Tumor Immunology. Submit by 21 February 2027.

Submit Your Paper

Topics include, but are not limited to:

Innovations in Cancer Vaccine Development

  • Novel adjuvants for enhanced immune response
  • Targeting neoantigens for personalized therapies
  • Combination strategies with checkpoint inhibitors

Tumor Microenvironment and Immune Response

  • Impact of tumor microenvironment on vaccine efficacy
  • Role of immune suppressive cells
  • Dynamics of immune evasion mechanisms

Clinical Trials and Regulatory Challenges

  • Designing adaptive trial methodologies
  • Evaluating safety and efficacy in diverse populations
  • Navigating regulatory pathways for approval

Biomarkers for Response Prediction

  • Identifying predictive biomarkers for vaccine efficacy
  • Utilizing liquid biopsies for monitoring
  • Role of genomic profiling in tailoring therapy

Interdisciplinary Approaches in Immunotherapy

  • Collaboration between oncologists and immunologists
  • Integrating computational biology in vaccine design
  • Psychosocial factors affecting patient outcomes

Important Dates

Conference opens in

00days
00hours
00min
00sec
  1. Step 1

    Submission Deadline

  2. Step 2

    Registration Deadline

  3. Step 3

    Conference Date

Download

Get the official templates and forms for ICCVTI 2027. Use the latest versions when preparing your submission.

Peer Review Process

Follow each step from abstract submission to awards and recognition.

Yanjiuconference peer review process: 12 steps from abstract submission to awards and recognition

See You in Makassar This March

Present your research, meet peers from over 50 countries and help shape the future of Cancer Vaccines and Tumor Immunology.